4
Changes in Ownership
Edesa Biotech, Inc. Filed Acc 0001144204-16-140709
Options or other derivatives
- Chief Financial Officer acquired 10,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| NIFFENEGGER KATHI Chief Financial Officer | 2016-12-20 | Grant or award · Share Option (Right to Buy) | +10,000 | 10,000 | D: show line 1 in the form |
Loading xslF345X03/v455475_4.xml…